HIGHLIGHTS
- What: This review describes atherosclerosis as a disease of low-grade vascular inflammation that is driven by a myriad of different pro-inflammatory processes and cellular players.
- Who: Liqing Zang et al. from the Mie University, Japan have published the paper: Moving from lipids to leukocytes: in ammation and immune cells in atherosclerosis, in the Journal: (JOURNAL)
- How: Similar results were obtained using low doses of the anti-inflammatory drug colchicine (Nidorf et_al 2020). This review describes atherosclerosis as a disease of low-grade vascular inflammation that is driven by a myriad of . . .

If you want to have access to all the content you need to log in!
Thanks :)
If you don't have an account, you can create one here.